Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma

Published:2017-01-11 Issue: Volume:7 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Jiang Zhiwu,Jiang Xiaofeng,Chen Suimin,Lai Yunxin,Wei Xinru,Li Baiheng,Lin Simiao,Wang Suna,Wu Qiting,Liang Qiubin,Liu Qifa,Peng Muyun,Yu Fenglei,Weng Jianyu,Du Xin,Pei Duanqing,Liu Pentao,Yao Yao,Xue Ping,Li Peng

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. CD4+CD25+CD127low regulatory T cells play predominant anti-tumor suppressive role in hepatitis B virus associated hepatocellular carcinoma;Sharma;Front Immunol,2015

2. Hepatocellular carcinoma: diagnosis, management, and prognosis;Page;Surg Oncol Clin N Am,2014

3. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma;Jayachandran;J Hematol Oncol,2016

4. Strategies for safer liver surgery and partial liver transplantation;Clavien;N Engl J Med,2007

5. Hepatocellular carcinoma: from diagnosis to treatment;Waghray;World J Hepatol,2015

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma;Clinical and Experimental Medicine;2024-08-28

2. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside;Experimental Hematology & Oncology;2024-08-01

3. Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies;Frontiers in Bioscience-Landmark;2024-07-24

4. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma;Cancers;2024-07-22

5. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07